These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 17376685)

  • 1. Centronuclear myopathy due to a de novo dominant mutation in the skeletal muscle ryanodine receptor (RYR1) gene.
    Jungbluth H; Zhou H; Sewry CA; Robb S; Treves S; Bitoun M; Guicheney P; Buj-Bello A; Bönnemann C; Muntoni F
    Neuromuscul Disord; 2007 Apr; 17(4):338-45. PubMed ID: 17376685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms and phenotypic variation in RYR1-related congenital myopathies.
    Zhou H; Jungbluth H; Sewry CA; Feng L; Bertini E; Bushby K; Straub V; Roper H; Rose MR; Brockington M; Kinali M; Manzur A; Robb S; Appleton R; Messina S; D'Amico A; Quinlivan R; Swash M; Müller CR; Brown S; Treves S; Muntoni F
    Brain; 2007 Aug; 130(Pt 8):2024-36. PubMed ID: 17483490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minicore myopathy with ophthalmoplegia caused by mutations in the ryanodine receptor type 1 gene.
    Jungbluth H; Zhou H; Hartley L; Halliger-Keller B; Messina S; Longman C; Brockington M; Robb SA; Straub V; Voit T; Swash M; Ferreiro A; Bydder G; Sewry CA; Müller C; Muntoni F
    Neurology; 2005 Dec; 65(12):1930-5. PubMed ID: 16380615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance imaging of muscle in congenital myopathies associated with RYR1 mutations.
    Jungbluth H; Davis MR; Müller C; Counsell S; Allsop J; Chattopadhyay A; Messina S; Mercuri E; Laing NG; Sewry CA; Bydder G; Muntoni F
    Neuromuscul Disord; 2004 Dec; 14(12):785-90. PubMed ID: 15564033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanding the clinical, pathological and MRI phenotype of DNM2-related centronuclear myopathy.
    Susman RD; Quijano-Roy S; Yang N; Webster R; Clarke NF; Dowling J; Kennerson M; Nicholson G; Biancalana V; Ilkovski B; Flanigan KM; Arbuckle S; Malladi C; Robinson P; Vucic S; Mayer M; Romero NB; Urtizberea JA; García-Bragado F; Guicheney P; Bitoun M; Carlier RY; North KN
    Neuromuscul Disord; 2010 Apr; 20(4):229-37. PubMed ID: 20227276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RYR1-Related Myopathies: Clinical, Histopathologic and Genetic Heterogeneity Among 17 Patients from a Portuguese Tertiary Centre.
    Samões R; Oliveira J; Taipa R; Coelho T; Cardoso M; Gonçalves A; Santos R; Melo Pires M; Santos M
    J Neuromuscul Dis; 2017; 4(1):67-76. PubMed ID: 28269792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and genetic diagnosis of centronuclear myopathies in seven Chinese patients.
    Zhao Y; Zhao Z; Shen H; Bing Q; Hu J
    Neurol Sci; 2018 Dec; 39(12):2043-2051. PubMed ID: 30232666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RYR1 mutations are a common cause of congenital myopathies with central nuclei.
    Wilmshurst JM; Lillis S; Zhou H; Pillay K; Henderson H; Kress W; Müller CR; Ndondo A; Cloke V; Cullup T; Bertini E; Boennemann C; Straub V; Quinlivan R; Dowling JJ; Al-Sarraj S; Treves S; Abbs S; Manzur AY; Sewry CA; Muntoni F; Jungbluth H
    Ann Neurol; 2010 Nov; 68(5):717-26. PubMed ID: 20839240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Centronuclear (myotubular) myopathy.
    Jungbluth H; Wallgren-Pettersson C; Laporte J
    Orphanet J Rare Dis; 2008 Sep; 3():26. PubMed ID: 18817572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular, biochemical and molecular changes in muscles from patients with X-linked myotubular myopathy due to MTM1 mutations.
    Bachmann C; Jungbluth H; Muntoni F; Manzur AY; Zorzato F; Treves S
    Hum Mol Genet; 2017 Jan; 26(2):320-332. PubMed ID: 28007904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common and variable clinical, histological, and imaging findings of recessive RYR1-related centronuclear myopathy patients.
    Abath Neto O; Moreno CAM; Malfatti E; Donkervoort S; Böhm J; Guimarães JB; Foley AR; Mohassel P; Dastgir J; Bharucha-Goebel DX; Monges S; Lubieniecki F; Collins J; Medne L; Santi M; Yum S; Banwell B; Salort-Campana E; Rendu J; Fauré J; Yis U; Eymard B; Cheraud C; Schneider R; Thompson J; Lornage X; Mesrob L; Lechner D; Boland A; Deleuze JF; Reed UC; Oliveira ASB; Biancalana V; Romero NB; Bönnemann CG; Laporte J; Zanoteli E
    Neuromuscul Disord; 2017 Nov; 27(11):975-985. PubMed ID: 28818389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Congenital myopathies].
    Cabello A; Ricoy-Campo JR
    Rev Neurol; 2003 Oct 16-31; 37(8):779-86. PubMed ID: 14593641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An autosomal dominant congenital myopathy with cores and rods is associated with a neomutation in the RYR1 gene encoding the skeletal muscle ryanodine receptor.
    Monnier N; Romero NB; Lerale J; Nivoche Y; Qi D; MacLennan DH; Fardeau M; Lunardi J
    Hum Mol Genet; 2000 Nov; 9(18):2599-608. PubMed ID: 11063719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel dynamin-2 gene mutation associated with a late-onset centronuclear myopathy with necklace fibres.
    Casar-Borota O; Jacobsson J; Libelius R; Oldfors CH; Malfatti E; Romero NB; Oldfors A
    Neuromuscul Disord; 2015 Apr; 25(4):345-8. PubMed ID: 25633151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adult-onset autosomal dominant centronuclear myopathy due to BIN1 mutations.
    Böhm J; Biancalana V; Malfatti E; Dondaine N; Koch C; Vasli N; Kress W; Strittmatter M; Taratuto AL; Gonorazky H; Laforêt P; Maisonobe T; Olivé M; Gonzalez-Mera L; Fardeau M; Carrière N; Clavelou P; Eymard B; Bitoun M; Rendu J; Fauré J; Weis J; Mandel JL; Romero NB; Laporte J
    Brain; 2014 Dec; 137(Pt 12):3160-70. PubMed ID: 25260562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscle magnetic resonance imaging in congenital myopathies due to ryanodine receptor type 1 gene mutations.
    Klein A; Jungbluth H; Clement E; Lillis S; Abbs S; Munot P; Pane M; Wraige E; Schara U; Straub V; Mercuri E; Muntoni F
    Arch Neurol; 2011 Sep; 68(9):1171-9. PubMed ID: 21911697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late-onset axial myopathy with cores due to a novel heterozygous dominant mutation in the skeletal muscle ryanodine receptor (RYR1) gene.
    Jungbluth H; Lillis S; Zhou H; Abbs S; Sewry C; Swash M; Muntoni F
    Neuromuscul Disord; 2009 May; 19(5):344-7. PubMed ID: 19303294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI in DNM2-related centronuclear myopathy: evidence for highly selective muscle involvement.
    Schessl J; Medne L; Hu Y; Zou Y; Brown MJ; Huse JT; Torigian DA; Jungbluth H; Goebel HH; Bönnemann CG
    Neuromuscul Disord; 2007 Jan; 17(1):28-32. PubMed ID: 17134899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congenital neuromuscular disease with uniform type 1 fiber and RYR1 mutation.
    Sato I; Wu S; Ibarra MC; Hayashi YK; Fujita H; Tojo M; Oh SJ; Nonaka I; Noguchi S; Nishino I
    Neurology; 2008 Jan; 70(2):114-22. PubMed ID: 17538032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel mutation in the DNM2 gene impairs dynamin 2 localization in skeletal muscle of a patient with late onset centronuclear myopathy.
    Kierdaszuk B; Berdynski M; Karolczak J; Redowicz MJ; Zekanowski C; Kaminska AM
    Neuromuscul Disord; 2013 Mar; 23(3):219-28. PubMed ID: 23374900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.